This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish (read more).

Resources - Whitepapers

Drug Serialization — Local Knowledge The Key To Protecting Patients In U.S. And International Markets

Evolving track-and-trace rules in key markets are driving pharmaceutical industry demand for adaptable contractors with regional expertise, according to Ian Parsonage, Senior Director, Global Serialization Services at PCI Pharma Services.

Beginning in late November 2017, pharmaceuticals sold in the U.S. must be marked with a National Drug Code (NDC), a serial number, a lot number, and an expiration date. The requirement, stipulated in 2013’s Drug Quality and Security Act (DQSA) (H.R. 3204), is designed to harmonize existing state-to-state variations in track-and-trace laws.

Drug Serialization

December 20, 2016

PCI Welcomes UK Government to US Center of Excellence and Headquarters

PCI Pharma Services welcomed an official visit by the UK Government to our US Headquarters in Philadelphia, Pennsylvania this week.... View Article

PCI Welcomes Laura Zurlinden to West Coast Sales Team

PCI Pharma Services is pleased to announce Laura Zurlinden has accepted the role of Director of Business Development – West... View Article